Natalie Nunez Gomez

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

M. Netea, B. Strober, M. Lebwohl, 2022, Dermatology and Therapy.

Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials.

B. Strober, M. Lebwohl, G. Kokolakis, 2022, The British journal of dermatology.